6th Edition of Global Conference on
Addiction Medicine, Behavioral Health and Psychiatry
October 20-22, 2025 | Orlando, Florida, USA
Drug-Induced Cognitive Impairments
Drug-induced cognitive impairments occur when substances like alcohol, stimulants, or opioids alter brain function, leading to difficulties in memory, attention, or decision-making. Chronic use disrupts neural pathways, particularly in the prefrontal cortex and hippocampus, responsible for executive functions and memory consolidation. These impairments can hinder daily activities, learning abilities, and social interactions. Cognitive deficits vary by substance and usage patterns but can sometimes persist even after cessation, emphasizing the importance of early intervention. Treatment often includes detoxification, cognitive rehabilitation therapies, and neuroprotective medications to restore brain health. Understanding the mechanisms of drug-induced cognitive impairments aids in developing targeted strategies to mitigate long-term effects and improve the quality of life for affected individuals.
Nile Stanley
University of North Florida, United States
Ann Marie Leonard Zabel
Curry College, United States
Denis Larrivee
University of Navarra, Spain
Scharbach Hugues
Paris University, France
Alphonsus Obayuwana
Triple-H Project LLC, United States
Malasri Chaudhery Malgeri
Recovery com, United States
Jana Furstova
Palacký University Olomouc, Czech RepublicSubmit your abstract Today
Title : Tailoring biblio-poetry therapies using AI and biofeedback for addiction treatment
Nile Stanley, University of North Florida, United States
Title : The A-B-C of happiness coaching
Alphonsus Obayuwana, Triple-H Project LLC, United States
Title : Clinical pharmacology of marijuana: Update 2024
Frederick J Goldstein, Philadelphia College of Osteopathic Medicine, United States
Title : Trait-based recovery: Evidence-based trait activation to reduce depression, anxiety, and improve client engagement in addiction treatment
Jason Glenn Roop, The Center for Trait-Based Transformation, United States
Title : An investigation of the factors responsible for ubstance abuse from a cognitive perspective based on a mixed method approach
Adewole Olukorede, Literary Edifice, Italy
Title : A Long-Acting Naltrexone Implant (for Opioid Use Disorder: First-in-Human Phase I Trial)
Steven M Cohen, Akyso Therapeutics, United States